当前位置:首页 - 行情中心 - 昊帆生物(301393) - 财务分析 - 现金流量表

昊帆生物

(301393)

  

流通市值:20.99亿  总市值:53.84亿
流通股本:4210.48万   总股本:1.08亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金351,177,040.14219,281,466.18107,419,345.52417,522,266.54
  收到的税费返还13,832,636.929,525,220.985,628,774.4716,326,244.2
  收到其他与经营活动有关的现金28,565,978.8412,320,633.3212,886,538.5442,663,572.48
  经营活动现金流入小计393,575,655.9241,127,320.48125,934,658.53476,512,083.22
  购买商品、接受劳务支付的现金217,791,133.04117,417,889.165,890,768.39243,874,825.37
  支付给职工以及为职工支付的现金62,338,254.8140,461,338.7224,923,119.6364,568,458.8
  支付的各项税费35,699,508.6224,022,829.7913,134,991.4228,057,498.58
  支付其他与经营活动有关的现金30,023,630.8414,147,395.589,294,281.113,637,740.82
  经营活动现金流出小计345,852,527.31196,049,453.19113,243,160.54350,138,523.57
  经营活动产生的现金流量净额47,723,128.5945,077,867.2912,691,497.99126,373,559.65
二、投资活动产生的现金流量:
  收回投资收到的现金4,018,603,927.452,301,963,026.62500,854,381.761,214,065,274
  取得投资收益收到的现金0--10,950,889.64
  处置固定资产、无形资产和其他长期资产收回的现金净额1,917,558.641,398,499.0256,276.8281,034.43
  处置子公司及其他营业单位收到的现金净额0---
  收到的其他与投资活动有关的现金11,000,00011,500,000-500,886,331.95
  投资活动现金流入小计4,031,521,486.092,314,861,525.64500,910,658.581,725,983,530.02
  购建固定资产、无形资产和其他长期资产支付的现金92,288,821.8754,617,680.8823,287,060.01107,754,234.19
  投资支付的现金3,529,046,308.41,664,046,308.4299,075,3602,523,893,903.03
  质押贷款净增加额0---
  取得子公司及其他营业单位支付的现金55,603,114.98---
  支付其他与投资活动有关的现金200,000200,000-33,690,081.95
  投资活动现金流出小计3,677,138,245.251,718,863,989.28322,362,420.012,665,338,219.17
  投资活动产生的现金流量净额354,383,240.84595,997,536.36178,548,238.57-939,354,689.15
三、筹资活动产生的现金流量:
  吸收投资收到的现金4,601,100---
  取得借款收到的现金75,000,000---
  筹资活动现金流入平衡项目0---
  筹资活动现金流入小计79,601,100---
  偿还债务支付的现金195,990,000---
  分配股利、利润或偿付利息支付的现金28,881,609.1328,347,540.78-40,192,719.5
  支付其他与筹资活动有关的现金1,458,548.53734,874.9474,955.2544,310,954.73
  筹资活动现金流出小计226,330,157.6629,082,415.68474,955.2584,503,674.23
  筹资活动产生的现金流量净额-146,729,057.66-29,082,415.68-474,955.25-84,503,674.23
四、汇率变动对现金及现金等价物的影响-3,639,489.76-1,206,677.33-340,058.073,329,387.87
五、现金及现金等价物净增加额251,737,822.01610,786,310.64190,424,723.24-894,155,415.86
  加:期初现金及现金等价物余额361,081,038.91361,081,038.91361,081,038.911,255,236,454.77
  期末现金及现金等价物余额612,818,860.92971,867,349.55551,505,762.15361,081,038.91
补充资料:
  净利润-75,884,801.99-134,052,917.06
  资产减值准备-997,998.58-5,170,989.26
  固定资产和投资性房地产折旧-12,718,771.51-17,695,255.12
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-12,718,771.51-17,695,255.12
  无形资产摊销-288,335.26-573,840.36
  长期待摊费用摊销-70,412.98-75,901.67
  处置固定资产、无形资产和其他长期资产的损失-93,989.15-32,052.89
  固定资产报废损失-30,860.38-356,785.12
  公允价值变动损失--5,444,086.14--5,636,108.35
  财务费用-1,410,756.05--4,434,344.37
  投资损失--9,950,840.4--10,950,889.64
  递延所得税--673,997.09-151,294.1
  其中:递延所得税资产减少--396,345.74--721,603.28
    递延所得税负债增加--277,651.35-872,897.38
  存货的减少--21,251,383.03--4,366,542.56
  经营性应收项目的减少--39,907,425.79--25,747,290.14
  经营性应付项目的增加-27,017,450.77-13,137,965.19
  其他-2,897,780.19-4,536,644.39
  现金的期末余额-971,867,349.55-361,081,038.91
  减:现金的期初余额-361,081,038.91-1,255,236,454.77
  现金及现金等价物的净增加额-610,786,310.64--894,155,415.86
公告日期2025-10-292025-08-292025-04-282025-04-11
审计意见(境内)标准无保留意见
TOP↑